Revenue, last quarter
$404.6K
−44.5% vs same quarter last year
Net income
−$4.6M
−8.8% vs same quarter last year
EPS, diluted
−$0.53
+74.1% vs same quarter last year
Operating cash flow
−$4.8M
+10.6% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $2.3M | −$18.6M |
| FY24 | $1.6M | −$18.8M |
| FY23 | $1.1M | −$14.2M |
| FY22 | $1.2M | −$11.4M |
| FY21 | $1.2M | −$7.5M |
| FY20 | $1M | −$6.9M |
| FY19 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 62% | −767% | −812.3% |
| FY24 | 66.6% | −1091.8% | −1155% |
| FY23 | 64.5% | −1353.4% | −1329.1% |
| FY22 | 63.4% | −961.7% | −944.6% |
| FY21 | 68.6% | −706.7% | −639% |
| FY20 | 70.5% | −668% | −666.2% |
| FY19 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$19.2M |
| FY24 | −$20.2M |
| FY23 | −$11.4M |
| FY22 | −$11.1M |
| FY21 | −$8.2M |
| FY20 | −$4.9M |
| FY19 | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | - |
| FY24 | $60.8K |
| FY23 | $230K |
| FY22 | $0 |
| FY21 | - |
| FY20 | - |
| FY19 | - |
- Femasys
- Healthcare median
Show the numbers
| Year | Femasys | Healthcare median |
|---|---|---|
| FY25 | −812.3% | −30.6% |
| FY24 | −1155% | −47% |
| FY23 | −1329.1% | −58% |
| FY22 | −944.6% | −80.4% |
| FY21 | −639% | −71.8% |
| FY20 | −666.2% | −62.2% |
| FY19 | - | −46.2% |